Skip to main content
PLOS One logoLink to PLOS One
. 2021 Oct 21;16(10):e0258647. doi: 10.1371/journal.pone.0258647

Accuracy of BIS monitoring using a novel interface device connecting conventional needle-electrodes and BIS sensors during frontal neurosurgical procedures

Hideki Harada 1,*, Seiya Muta 2, Tatsuyuki Kakuma 3, Misa Ukeda 4, So Ota 4,5, Maiko Hirata 4, Hiroshi Fujioka 6, Osamu Nakashima 2, Barbara Dietel 7, Miyuki Tauchi 7,*
Editor: Laura Pasin8
PMCID: PMC8530286  PMID: 34673803

Abstract

Background

Bispectral index (BIS) monitoring is a widely used non-invasive method to monitor the depth of anesthesia. However, in the event of surgeries requiring a frontal approach, placement of the electrode may be impossible at the designated area to achieve a proper BIS measurement.

Methods

We developed an investigational interface device to connect needle-electrodes to BIS sensors. The safety and clinical performance were investigated in patients who underwent surgery. Direct BIS values from a disposable BIS electrode and indirect values via the interface device were simultaneously recorded from the same areas of electrode placement in a single patient. The agreement between the direct and indirect BIS values was statistically analyzed.

Results

The interface device with a silver electrode demonstrated sufficient electric conduction to transmit electroencephalogram signals. The overall BIS curves were similar to those of direct BIS monitoring. Direct and indirect BIS values from 18 patients were statistically analyzed using a linear mixed model and a significant concordance was confirmed (indirect BIS = 7.0405 + 0.8286 * direct BIS, p<0.0001). Most observed data (2582/2787 data points, 92.64%) had BIS unit differences of 10 or less.

Conclusions

The interface device provides an opportunity for intraoperative BIS monitoring of patients, whose clinical situation does not permit the placement of conventional adhesive sensors at the standard location.

Introduction

Bispectral index (BIS) monitoring is widely used to assess the depth of anesthesia [1]. Currently, BIS sensors are placed on the forehead to measure frontal lobe electroencephalogram (EEG) [2]. Surgical stimulations may be detected by EEG responses from frontal areas but not from central, parietal, temporal, or occipital areas [3]. Accordingly, EEG responses, as well as BIS have been shown to be topographically dependent [4]. The most and only reliable area of the sensor placement is the forehead, for which the BIS system has been developed and validated. It is currently considered that the use of other areas for sensor attachment is not easily interchangeable and requires very much caution [5].

In the events of surgeries requiring a frontal approach or concurrent regional oxygen saturation (rSO2) monitoring, optimal placement of the electrode may not be possible to achieve a proper BIS measurement. To enable proper BIS monitoring in such surgeries, we sought to develop an interface device to connect conventional EEG needle-electrodes to BIS sensors.

In the present study, we assessed clinical performance and safety of a novel interface device, which connects the BIS Vista™ system to conventional EEG needle-electrodes, aiming to achieve a reliable BIS monitoring without obstructing frontal surgical procedures or rSO2 monitoring.

Materials and methods

Ethical statement

The interface device presented in this manuscript was an investigational device. Written consent was obtained from all patients following detailed information about the study approach. The prospective clinical study was reviewed and approved by the independent ethic committee of the University of Kurume (No. 16050; approved on June 20, 2016; PI: H. Harada) and was carried out in accordance with the Declaration of Helsinki. Following the Japanese guideline for an unapproved medical device in clinical studies [6], patient recruitment was started before registration of the study in a public domain to protect the intellectual property. It was registered at University hospital Medical Information Network (UMIN000031217, February 9. 2018, PI: H. Harada) after the patent was filed. We confirm that all ongoing and related trials for this device are registered. This manuscript adheres to the EQUATOR guidelines (SAMPL and STARD).

Development of an interface device

The interface device

The device was constructed to interface between the subdermal needle-electrodes (NE-220B; Technomed Europe, Maastricht, Netherland) and the Covidien BIS™ Quatro sensor (Minneapolis, MN, USA; Fig 1A–1C). An end of the lead cable (L200) was mounted with a plug connector MS155-S type for the needle-electrodes. Another end was mounted with a plate electrode (diameter 10mm; thickness 0.25mm), made of either stainless steel, silver/ silver chloride (Ag/AgCl), or silver (Ag) to test feasibility. The plate electrodes were integrated into a liner card made of silicone-coated high-impact polystyrene, which lines the disposable BIS™ Quatro sensors in the package. The liner card enables a precise and secure connection of the plate electrodes and a BIS™ Quatro sensor.

Fig 1. The interface device.

Fig 1

(A) Specifications of the interface device. (B) The interface device. Four electrodes are integrated into a silicone-coated high-impact polystyrene liner card. (C) The interface device connected to the needle-electrodes and a BIS™ Quatro sensor. BIS: bispectral index.

Impedance check

The BIS monitoring system performs automatic impedance check whether the electrical conduction of sensors is sufficient for EEG analyses. Four electrodes were connected to a BISTM Quatro sensor via the interface device (Fig 1C), and the needle-electrodes were submerged in saline. The impedance of all needle-electrodes, of the ground electrode, and between two electrodes was measured under a condition of 128Hz/1nA. BIS monitoring system shows “PASS” and BIS can be calculated when following criteria are met: (1) The impedance values of each electrode are less than 7.5 kΩ; (2) the impedance value of the ground electrode is less than 30 kΩ; and (3) the impedance values between two electrodes (No. 1 vs. 3 and No. 1 vs. 4) are less than 30 kΩ.

Safety evaluation

Safety of the device was investigated in compliance with the IEC 60601–1 standard “Medical Electrical Equipment–Part 1: General Requirement for Safety and Essential performance”. Leakage tests were performed to preclude any risk for an electrical shock caused by direct contact with the device. Two randomly chosen devices were examined under normal conditions and under single-fault conditions with an interruption of one power supply conductor at a time, with regards to earth leakage current, touch current, patient leakage current (Types BF), and patient auxiliary current. All measurements were done by Nihon Koden Corp. (Kurume, Fukuoka, Japan).

Clinical studies

Patients

Patients were asked for their willingness to participate in the study in a convenience sampling manner when the principal investigator was on duty for their planned neuro- (clinical study 1) or orthopedic (clinical study 2) surgery. Inclusion criteria were ≥20 years old and class I or II of the American Society of Anesthesiologists (ASA) Physical Status Classification. Patients in clinical study 2 with the following conditions were excluded: altered levels of consciousness before the surgery due to intracranial disorders; neurological disorders; psychiatric disorders; pathergy test positive; and metal hypersensitivity. Additionally, patients with injury and/or skin disease on the forehead or surgical procedures impeding BIS sensor attachment at the forehead were excluded, while patients were asked for their agreement to participate in the clinical study 1 only when his/her clinical condition did not allow a conventional BIS monitoring.

Safety assessment

All adverse events (AEs) in the entire perioperative period were recorded. Subdermal needle-electrodes used in the study are known occasionally to induce subcutaneous bleeding and infection. These AEs were appropriately treated.

Clinical study 1: BIS measurement using the interface device. This study was carried out as proof-of-concept without a reference test. Four needle-electrodes were placed on the patient’s forehead immediately after anesthesia induction (propofol 2mg/kg, remifentanil 0.25μg/kg per min, and rocuronium 0.6mg/kg). The needle-electrodes were then connected to the BIS monitor via the interface device. The BIS, electromyogram (EMG), and signal quality index (SQI) were recorded throughout the anesthesia maintenance period along with general monitoring of anesthesia.

Clinical study 2: Comparison between BIS values obtained directly from BIS electrode sensor (dBIS) and indirectly from needle-electrodes via the interface device (indBIS). The accuracy of the BIS values obtained indirectly via the interface device (indirect recording; indBIS) was assessed by comparing with conventional directly-recorded BIS (dBIS) as the reference standard. Patients received a disposable BISTM Bilateral sensor (Covidien) on the forehead following the manufacturer’s instruction. The RE and RT electrodes were connected to the interface device. The anesthesia was induced and needle-electrodes were inserted subcutaneously under the adhesive pads of BISTM Bilateral LE and LT sensors without direct contact with LE and LT electrodes (Fig 2). The BISTM Bilateral sensor was connected to the BIS™ Complete 4-Channel Monitoring System (Covidien) to record signals directly through BISTM Bilateral sensors LE and LT and indirectly from the needle-electrodes at the same areas but via the interface device attached to RE and RT. Using this sensor placement strategy, the EEG signals collected from both methods should be nearly identical. After impedance was checked, BIS, EMG, and SQI were recorded throughout the surgery until emergence. Anesthesia was induced with propofol (2mg/kg), remifentanil (0.25μg/kg per min), and rocuronium (0.6mg/kg), and maintained with O2-air-sevoflurane.

Fig 2. The interface device setting for direct and indirect recording.

Fig 2

The setting for the clinical study 2 using BIS™ Bilateral sensors. Left BIS™ Bilateral sensor is attached at the forehead following the manufacturer’s instruction. Two needle-electrodes are inserted subcutaneously adjacent to the LE and LT electrodes and connected to the RE and RT side via the interface device. Arrows designate the signal paths (orange arrows: indirect bispectral index (BIS) recording; green arrows: direct BIS recording). BIS: bispectral index, EEG: electroencephalogram.

Statistical analyses

BIS values were automatically stored by BIS VISTATM software. BIS values of each time point were individually plotted and a correlation coefficient was calculated to evaluate the agreement between dBIS and indBIS. The main object of this study was to examine agreement between two methods. The linear mixed model was used to test concordance between dBIS and indBIS (S1 Text). With regard to sample size and statistical power, formal power analysis was not conducted since there were no clear scientific and clinical guidelines for “equivalence margins” for agreement. Variabilities of measurements among patients were included as random parameters for intercepts and slopes. The adequacy of the model fit was examined using marginal and conditional residuals. Additionally, data were stratified according to the dBIS value (<60 or 60+) and exploratory analyzed. Tests were two-tailed and a p-value less than 0.05 was considered statistically significant. We set BIS value differences of ±10 between dBIS and indBIS, which were considered clinically acceptable for sake of interpreting results of data analyses.

Bland-Altman analyses were performed to assess the agreement between dBIS and indBIS. In consideration of unequal numbers of BIS observation points in repeated measurements of continuously changing values, the mixed-effects method was used to estimate the mean bias and the limits of agreement [7] (S1 Text).

All statistical analyses were performed with SAS® software.

Results

The interface device with Ag electrode has sufficient electric conduction for BIS measurement

The interface device was constructed with a plate electrode made of three different materials (stainless steel, Ag/AgCl, and Ag). The interface device with a stainless-steel electrode did not pass the check, indicating high impedance that was outside of the measurable range. The Ag/AgCl electrode showed a measurable impedance of around 1000 Ω. However, BIS could not be obtained due to noise, when the interface was connected to the Quatro sensor. The Ag electrode met all the four criteria, and the BIS values were successfully recorded. Only the Ag electrode generated sufficient electric conduction. Therefore, all clinical studies were carried out using the interface device with Ag electrodes.

IndBIS via the interface device demonstrated a reasonable curve during surgery (clinical study 1)

Six patients underwent the BIS measurement using four needle-electrodes via the interface (Fig 3A, 3B). A representative graph for the values of EMG, SQI, and BIS is shown in Fig 3C. BIS was stable during the surgery [42.5 (2.18); mean (SD), otherwise noted]. SQI was consistently high [96.8 (4.23)] and EMG was consistently low [27.4 (0.51)]. SQI had downward peaks every 10 min, which coincided with the automatic impedance check of the BIS system (Fig 3C; arrows). During the 10-minute recovery period, BIS increased gradually, along with the increase of EMG and the decrease of SQI. The curves of these three parameters were similar in other patients.

Fig 3. Indirect BIS recording via the interface device (clinical study 1).

Fig 3

(A) The flow of the participants in clinical study 1. (B) Needle-electrodes placement. Electrodes are inserted in four areas (arrows), where electrodes of a conventional BIS™ Quatro sensor are to be placed. (C) A representative plotting of SQI (green), BIS (red), and EMG (blue). The SQI decreases every 10 minutes, corresponding to the automatic impedance check of the BIS system. The period between X: Anesthesia induction until recovery; grey bar: Intubated period; black bar: Surgical procedure; BIS: bispectral index; EMG: electromyogram; SQI: signal quality index.

IndBIS via the interface device and dBIS demonstrated a strong agreement (clinical study 2)

A total of 21 patients participated in the study to compare BIS values between direct and indirect measurements. Patients’ characteristics are summarized in Table 1.

Table 1. Patients’ characteristicsa.

Demographic characteristics N = 21
Sex Male 12 patients (57.1%)
Female 9 patients (42.9%)
Age [year] 58.70 ± 15.00 (58, 32–79)
Height [cm] 160.81 ± 8.75 (160.2, 139.7–175.5)
Weight [kg] 62.56 ± 12.30 (61.2, 38.5–86.6)
Duration of monitoring [minutes] b 153.78 ± 85.06 (126, 61–423)

a Data are expressed as mean ± SD (median, min–max), otherwise noted.

b Data from 18 patients whose BIS data were obtained.

Data from three patients were excluded from analyses: In two patients, the indBIS was not obtained due to a failed impedance test; and in one patient, BIS was obtained but the impedance of the BIS™ Quatro sensor (LE and LT) was unusually high, affecting BIS values (Fig 4). Signals and corresponding BIS values obtained at the left side (LEFT or LT) were from the BIS™ Bilateral sensor directly. Signals and corresponding BIS values obtained at the right side (RIGHT or RT) were from the same sites on the left forehead, but with the needle-electrodes via the interface device (Fig 2). EEG waves form direct and indirect BIS sensors were reasonably similar (Fig 5A). Representative BIS, EMG, and SQI graphs, superimposing values obtained from direct and indirect sensors in a single patient are shown in Fig 5B–5D, respectively. Both BIS and EMG were very similar and the correlation coefficients were r2 = 0.8922 and 0.9779, respectively, demonstrating a strong agreement (Fig 5B’, 5C’). SQI showed regular downward peaks, corresponding to automatic impedance checks by the system (Fig 5D). Although SQI was not very closely matched between two recordings (Fig 5D’, r2 = 0.6709), its effect on the BIS correlation was minimal.

Fig 4. Flow of the participants in clinical study 2.

Fig 4

Fig 5. Results of clinical study 2.

Fig 5

(A) A representative captured image of the BIS monitor. The yellow line represents the EEG wave obtained from the left side (direct recording) and the blue line from the right side (indirect recording via the interface device). These two lines are nearly identical. (B-D) Representative BIS (B), EMG (C), and SQI (D) curves from a single patient with a strong agreement between direct and indirect BIS values. Curves from direct recording (orange lines) and indirect recording (blue lines) are superimposed. B’-D’ designate correlation analyses for BIS, EMG, and SQI, respectively. SQI for indirect recording was strongly affected by automatic impedance check every 10 minutes (D, blue line), resulting in the poor correlation coefficient of r2 = 0.6709, but it had a minimal impact on the correlation coefficients in BIS and EMG. The period between X: Anesthesia induction until recovery; grey bar: Intubated period; black bar: Surgical procedure; BIS: bispectral index, EMG: electromyogram, SQI: signal quality index.

Fig 6 shows an exemplary case from a single patient with unstable BIS between 100–200 minutes after recording started (Fig 6A). The unstable BIS was likely an artefact caused by unstable EMG signals (Fig 6B) because of intentional stimulations of orbicularis oculi muscle for neuromonitoring purposes. Even with this vigorous EMG disturbance, the dBIS and indBIS in this patient had only a slight discrepancy and were well correlated with the correlation coefficient of r2 = 0.7398 (Fig 6A’). SQI in the direct recording was strongly affected by impedance check and the correlation between SQI in the direct and indirect recording was poor (Fig 6C’, r2 = 0.2427). Notably, the poor SQI only slightly influenced the correlation in BIS (Fig 6A’).

Fig 6. An example of unstable BIS.

Fig 6

(A-C) Representative BIS (A), EMG (B), and SQI (C) curves from a single patient with an artefact noise in EMG. Curves from direct recording (orange lines) and indirect recording (blue lines) are superimposed. A’-C’ panels designate correlation analyses for BIS, EMG, and SQI, respectively. Due to stimulation of orbicularis oculi muscle, EMG was strongly disturbed (B), and the impedance check strongly affected SQI of direct recording during the orbicularis oculi muscle stimulation (C). Nevertheless, the effect on the BIS agreement was minimal (A’). The period between X: Anesthesia induction until recovery; grey bar: Intubated period; black bar: Surgical procedure period; BIS: bispectral index, EMG: electromyogram, SQI: signal quality index.

The linear mixed model included 2786 values (total = 2787) from 18 patients. The indBIS values were predicted as indBIS = 7.0405 + 0.8286 * dBIS (95% CI for the intercept and slope: 3.7410, 10.3399 and 0.7581, 0.8991, respectively) (Fig 7A, red line). Residual analyses showed an adequate model fit and the agreement between dBIS and indBIS values was statistically significant (p<0.0001).

Fig 7. Association between dBIS and indBIS.

Fig 7

(A) Plotting of all BIS values analyzed (2786 pairs of observations, including 2391 with BIS<60 and 395 with BIS ≥60). Red line: the prediction equation determined by the linear mixed model analysis for all data: indBIS = 7.0405 + 0.8286 * dBIS. Blue line: The prediction equation determined by the linear mixed model using stratified data: indBIS = 13.4156 + 0.6953 * dBIS (<60) and indBIS = –19.9564 +1.2515 * dBIS (60+). (B) and (C) Bland-Altman plot. The bias and 95% agreement limits (95%AL) estimated using all data are designated in red (B). The 95% ALs are narrower if it is estimated using dBIS < 60 than those of 60+ (blue lines, C). The dotted lines represent bias and solid lines represent 95% ALs. BIS: bispectral index, ALs: agreement limits.

In case the stratified data of indBIS <60 from all patients (n = 18) were used, indBIS values were predicted with the formula of indBIS = 21.6025 + 0.493 * dBIS (95% confidence interval (CI), 18.3675 and 24.8445 for the intercept, 0.4057 and 0.5804 for the slope) and the agreement was statistically significant (p<0.0001 for both). A total of 5 patients showed significantly deviant estimates of intercept, slope, or both (p-value range between <0.0001 and 0.0328). IndBIS 60+ data from 10 patients were excluded from analysis because they were less than 10% of all data points of the individual. The prediction curve was indBIS = –17.4773 + 1.1776 * dBIS (95% CI, –25.6271 and –9.3276 for the intercept, 1.0883 and 1.2669 for the slope), and indBIS and BIS values were significantly associated (p = 0.0014 for intercept; p<0.0001 for slope). The best fitted model was obtained by including both indBIS <60 (n = 18) and 60+ (n = 8) (p<0.0001). The prediction curves were indBIS = 13.4156 + 0.6953 * dBIS (95% CI, 9.6541 and 17.1771 for the intercept, 0.6110 and 0.7796 for the slope) for <60, and the slope was 1.2515 for 60+ (Fig 7A, blue line).

The Bland–Altman plot is shown in Fig 7B. Using all data values, the mean bias was estimated as 0.66 (red dotted line) and 95% limits of agreement were 12.13 and –10.80 (red solid lines) (Fig 7B, left panel). The median of the difference between indBIS and dBIS values was 0.00 (interquartile range, 5.00) and the mean was –0.66 (SD, 5.64). Six data points showed a difference of 25 or greater, including the maximum difference of 46. In the 2787 data points analyzed, 2582 data points (92.64%) demonstrated a difference of less than 10 BIS units between dBIS and indBIS values. In this regard, differences in individual patients seemed to play a role: In 14 patients, 2235/2334 (95.76%) of data points demonstrated the dBIS-indBIS difference of less than 10, while 4 patients showed lower concordance (347/453; 76.60%).

Additionally, the Bland–Altman analyses were carried out in two stratified data (<60 and 60+). The data set of <60 dBIS (n = 2391) had a bias of –0.08 (blue dotted line) and very narrow 95% limits of agreement (–10.04 to 9.88, blue solid lines) (Fig 7B, right panel). Meanwhile, the other data set of 60+ dBIS (n = 395) had broader agreement limits (–9.96 + 20.25) with a higher mean bias (5.14) than those of <60 dBIS (Fig 7B, right panel).

Safety assessment

No AE was observed during the perioperative period. No patients showed clinical signs of intraoperative awareness. No death occurred from the anesthesia induction until discharge. No major bleeding or subcutaneous bleeding did occur.

The leakage currents of the interface device were within the tolerance limits

The results of the leakage current measurement are displayed in Table 2. All measured currents were under the tolerance limits regulated by the IEC 60601–1 standard.

Table 2. Leakage currents.

Current Device 1 (μA) Device 2 (μA) Tolerance limit (μA)
Earth leakage current Normal condition 47 49 ≤ 5000
Single-fault condition 74 79 ≤ 10000
Touch current Normal condition 6 6 ≤ 100
Single-fault condition 1 1 ≤ 500
Patient leakage current (Type BF applied part) Normal condition, DC 0 0 ≤ 10
Normal condition, AC 1 1 ≤ 100
Single-fault condition, DC 0 0 ≤ 50
Single-fault condition, AC 1 1 ≤ 500
Patient auxiliary current Normal condition, DC 0 0 ≤ 10
Normal condition, AC 0 0 ≤ 10
Single-fault condition, DC 0 0 ≤ 50
Single-fault condition, AC 0 0 ≤ 50

BF: body floating; DC: direct current; AC: alternating current.

Discussion

We developed and investigated a novel interface device to connect conventional needle-electrodes and BIS monitoring sensors. The device was safe and indBIS values were similar to dBIS values.

This device enables BIS monitoring by collecting EEG signals from the forehead, even with limited space due to clinical situations. BIS monitoring has been investigated to place elsewhere, such as nasal [8], occipital [5, 9], auricular [10, 11], or mandibular [12] areas, and demonstrated a reasonable correlation, with the best concordance by the nasal dorsum measurement [8]. However, BIS has been considered to be topographically dependent [3, 4]. Therefore, validation is largely missing for the use of the forehead sensors at alternative areas and it is currently considered that the use of other areas is not easily interchangeable [5]. Our device largely overcomes the topographical problem. The 95% agreement limit in the present study was about the same or narrower than the nasal placement [8].

The idea to use needle electrodes for BIS measurement has been investigated previously [13, 14]. In these studies, BIS sensors and attached needle electrodes were modified, and tested in human patients or animals to demonstrate its interchangeability to the original sensor. In the present study, the interface device was to connect a commercially available BIS sensor to needle electrodes without modifying them. Using this simple device, the needle electrodes can be easily assembled with the BIS sensors by a practicing anesthetist without the need for special adjustments. Furthermore, the device is for multiple use.

As demonstrated in clinical study 2, dBIS and indBIS values showed a strong agreement. Notably, most of the observed indBIS values (2582/2787, 92.64%) were within the clinically acceptable 10-unit difference [5, 9] from dBIS. The most frequently observed difference between dBIS and indBIS in the entire dataset was 0. The 95% limits of agreement were narrow: Especially in the <60dBIS stratified group, it was –10.04 to 9.88. The difference tended to be bigger in the 60+ data set, which would require attention during clinical use of the interface. Collectively, these data showed that the indBIS is interchangeable to dBIS and clinically tolerable [5, 9].

There were 6 data points out of 2786 with an extremely large difference of 25 or greater (max. 46). All these BIS data were obtained from only two patients with obvious artefacts, such as the patient shown in Fig 6, who received neuromonitoring stimulations. Therefore, in such cases, the discrepancies are easily predictable and even the dBIS values are not to be trusted without other monitoring parameters.

In some patients, we found a large discrepancy in SQI. The reason for that is not clear but we believe from our data that it is not because of the needle electrodes nor the interface device, but because of the proprietary BIS algorism to determine SQI. The raw data from BIS monitoring using BISTM Bilateral sensor in VISTA system consistently showed that impedance was over the highest limit exactly every 10 minutes for 1 minute at three out of four electrodes. It is obviously an artificial pattern: therefore, we consider that the extremely high impedance is not an actual value, but an artificial one because of the automatic impedance checks. This timing coincides with the SQI spikes, indicating that SQI values are apparently dependent on the impedance values.

The impedance check lowers SQI more prominently in indBIS than in dBIS, probably because of the SQI calculation algorism. As written above, the impedance values exceeding the upper measurement limit are observed only in three out of four electrodes, regardless of the type of electrodes. The SQI for indBIS was based on two electrodes with unusually high impedance every 10 minutes but SQI for dBIS was based on one unaffected electrode and one electrode with unusually high impedance. Based on the facts described above, we found two supporting data sets: First, the SQI spikes were small in SQI data recorded using needle electrodes and the interface device only, being connected to a BIS™ Quatro sensor (Fig 3C). Next, we examined SQI data, recorded by using the BISTM Bilateral sensor (no needle electrodes, no interface device), from several patients. We confirmed that, in all cases, the impedance values exceeding the upper measurement limit were observed only in three out of four electrodes. When SQI are plotted for left- and right sides separately, there was a SQI discrepancy between the two SQIs, in most cases with larger SQI spikes at right side recording, which was used for indBIS recording.

From above observation, we concluded that the observed SQI spikes are not needle- or interface device-specific. In either case, the SQI spikes were not substantially influencing the BIS values as a fact from the data. With the one-side recording using BIS™ Quatro sensor, the effect is minimal, which is equivalent for the real-world practice.

Increased or unstable EMG activities influence BIS values [15]. In some patients (including the patient shown in Fig 6), EMG became unstable to some extent. This affected BIS values from both indirect and direct recordings. The disagreement between dBIS and indBIS was prominent in EMG (r2 = 0.5882), but moderate in BIS values. Indeed, BIS values showed a reasonably high correlation coefficient (r2 = 0.7398). The possible reasons for unstable EMG were mechanical artefacts, such as the movement of lead cables, surgical processes, impedance check, and patients’ movement. Although the discrepancy demands careful use of the interface device and great attention during surgery, EMG affects BIS obtained from the conventional adhesive sensor as well. Therefore, the unstable EMG-driven unstable BIS values are not necessarily an interface device-specific problem.

The observed small disagreement between dBIS and indBIS may not be caused by the interface device but the tolerance margins existing in BIS algorithms, and thus maybe unavoidable. In a previous study, BIS was monitored from a single patient using two BIS™ Quatro sensors and two recording machines [16]. They observed a discrepancy in two recordings and concluded that the failed reproducibility was because of the BIS system itself. We made effort to minimize potential bias seen in the study (i.e., two recording machines and adjacent but different areas of sensor placement): We placed the adhesive electrodes and the needle-electrodes directly next to each other in every patient and simultaneously recorded using a single BIS VISTA™ system to enable a precise comparison of two measures. The discrepancy we observed was smaller than that in the previous study [16], which let us consider that the disagreement between dBIS and indBIS were within the intrinsic tolerance margins and clinically not significant.

There is room for improvement in the interface device. The key improvement would be to obtain a constantly good SQI, which could be done by improving the adhesion of interface electrodes to the BIS conventional sensors. We used recycled liner cards, which were delivered with conventional BIS sensors and detached once from it. The two excluded cases from clinical study 2 were very likely due to poor adhesion between the interface device and the BIS™ Quatro sensor, resulting in high impedance. Slight differences in the attachment may account for the between-patients’ differences in the signal quality we observed.

The interface device can be connected not only to needle-electrodes but also commercially available plate electrodes for EEG measurements. The plate electrodes cannot be fixed so secure as the needle-electrodes, but require a small space for placement as well, and are non-invasive. Therefore, in case the electrodes are accessible by an anesthesiologist to re-assure the adhesion, the plate electrodes may be advantageous.

In conclusion, this investigational interface device provides an opportunity for intraoperative BIS monitoring of patients, whose clinical situation does not permit the use of conventional adhesive BIS sensors. There was a small discrepancy between BIS values in direct and indirect measurements, but it can be overcome with careful monitoring of SQI and EMG, also in conjunction with other available clinical signs for the intraoperative monitoring of anesthesia. The clinical benefit of the interface device is of great significance in monitoring anesthesia.

Supporting information

S1 Checklist

(PDF)

S2 Checklist

(PDF)

S1 Text. Statistical models.

(DOCX)

S1 File

(PDF)

S2 File

(PDF)

Acknowledgments

We thank all patients who agreed to participate in the study.

Data Availability

All summarized data are presented in the manuscript. Other data are all kept as raw data with patients' information. Because the size of participants is small and the study site locates in a small city, there is a privacy concern. Requests can be addressed to the ethics committee, Clinical Research Center, Kurume University Hospital (i_rinri@kurume-u.ac.jp), or to the principal investigator (Hideki Harada).

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Sigl JC, Chamoun NG. An introduction to bispectral analysis for the electroencephalogram. Journal of clinical monitoring. 1994;10(6):392–404. doi: 10.1007/BF01618421 . [DOI] [PubMed] [Google Scholar]
  • 2.Rampil IJ. A primer for EEG signal processing in anesthesia. Anesthesiology. 1998;89(4):980–1002. doi: 10.1097/00000542-199810000-00023 . [DOI] [PubMed] [Google Scholar]
  • 3.Kochs E, Bischoff P, Pichlmeier U, Schulte am Esch J. Surgical stimulation induces changes in brain electrical activity during isoflurane/nitrous oxide anesthesia. A topographic electroencephalographic analysis. Anesthesiology. 1994;80(5):1026–34. doi: 10.1097/00000542-199405000-00012 . [DOI] [PubMed] [Google Scholar]
  • 4.Pandin P, Van Cutsem N, Tuna T, D’Hollander A. Bispectral index is a topographically dependent variable in patients receiving propofol anaesthesia. British journal of anaesthesia. 2006;97(5):676–80. doi: 10.1093/bja/ael235 . [DOI] [PubMed] [Google Scholar]
  • 5.Dahaba AA, Xue JX, Zhao GG, Liu QH, Xu GX, Bornemann H, et al. BIS-vista occipital montage in patients undergoing neurosurgical procedures during propofol-remifentanil anesthesia. Anesthesiology. 2010;112(3):645–51. doi: 10.1097/ALN.0b013e3181cf4111 . [DOI] [PubMed] [Google Scholar]
  • 6.Guidance on clinical research with unapproved medical devices, (2011). [Google Scholar]
  • 7.Parker RA, Weir CJ, Rubio N, Rabinovich R, Pinnock H, Hanley J, et al. Application of Mixed Effects Limits of Agreement in the Presence of Multiple Sources of Variability: Exemplar from the Comparison of Several Devices to Measure Respiratory Rate in COPD Patients. PLoS One. 2016;11(12):e0168321. doi: 10.1371/journal.pone.0168321 ; PubMed Central PMCID: PMC5156413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Nelson P, Nelson JA, Chen AJ, Kofke WA. An alternative position for the BIS-Vista montage in frontal approach neurosurgical cases. J Neurosurg Anesthesiol. 2013;25(2):135–42. Epub 2013/03/05. doi: 10.1097/ANA.0b013e31826ca3a0 . [DOI] [PubMed] [Google Scholar]
  • 9.Shiraishi T, Uchino H, Sagara T, Ishii N. A comparison of frontal and occipital bispectral index values obtained during neurosurgical procedures. Anesthesia and analgesia. 2004;98(6):1773–5, table of contents. doi: 10.1213/01.ANE.0000121344.69058.09 . [DOI] [PubMed] [Google Scholar]
  • 10.Brown B, Edwards M, Tay S. Acceptability of auricular vs frontal bispectral index values. British journal of anaesthesia. 2014;113(2):296. doi: 10.1093/bja/aeu244 . [DOI] [PubMed] [Google Scholar]
  • 11.Akavipat P, Hungsawanich N, Jansin R. Alternative placement of bispectral index electrode for monitoring depth of anesthesia during neurosurgery. Acta medica Okayama. 2014;68(3):151–5. doi: 10.18926/AMO/52655 . [DOI] [PubMed] [Google Scholar]
  • 12.Lee SY, Kim YS, Lim BG, Kim H, Kong MH, Lee IO. Comparison of bispectral index scores from the standard frontal sensor position with those from an alternative mandibular position. Korean journal of anesthesiology. 2014;66(4):267–73. doi: 10.4097/kjae.2014.66.4.267 ; PubMed Central PMCID: PMC4028552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Greene SA, Benson GJ, Tranquilli WJ, Grimm KA. Relationship of canine bispectral index to multiples of sevoflurane minimal alveolar concentration, using patch or subdermal electrodes. Comp Med. 2002;52(5):424–8. Epub 2002/10/31. . [PubMed] [Google Scholar]
  • 14.Hemmerling TM, Coimbra C, Harvey P, Choiniere M. Needle electrodes can be used for bispectral index monitoring of sedation in burn patients. Anesthesia and analgesia. 2002;95(6):1675–7, table of contents. Epub 2002/11/29. doi: 10.1097/00000539-200212000-00037 . [DOI] [PubMed] [Google Scholar]
  • 15.Dahaba AA. Different conditions that could result in the bispectral index indicating an incorrect hypnotic state. Anesthesia and analgesia. 2005;101(3):765–73. doi: 10.1213/01.ane.0000167269.62966.af . [DOI] [PubMed] [Google Scholar]
  • 16.Niedhart DJ, Kaiser HA, Jacobsohn E, Hantler CB, Evers AS, Avidan MS. Intrapatient reproducibility of the BISxp monitor. Anesthesiology. 2006;104(2):242–8. doi: 10.1097/00000542-200602000-00007 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Laura Pasin

29 Apr 2021

PONE-D-21-02149

Accuracy of BIS monitoring using a novel interface device connecting conventional needle-electrodes and BIS sensors during frontal neurosurgical procedures

PLOS ONE

Dear Dr. Harada,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Although interesting, the manuscript presents great limitations. In particular statistical analysis need to be improved. Please carefully address all Reviewers' comments, in particular the comments of Reviewer #4. 

Please submit your revised manuscript by 21/05/2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Laura Pasin

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for submitting your clinical trial to PLOS ONE and for providing the name of the registry and the registration number. The information in the registry entry suggests that your trial was registered after patient recruitment began. PLOS ONE strongly encourages authors to register all trials before recruiting the first participant in a study.

As per the journal’s editorial policy, please include in the Methods section of your paper:

1) your reasons for your delay in registering this study (after enrolment of participants started);

2) confirmation that all related trials are registered by stating: “The authors confirm that all ongoing and related trials for this drug/intervention are registered”.

3. Please include captions for *all* your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

4. We note that Figure [S2.BIS setting with the interface device (video)] includes an image of a patient in the study. 

As per the PLOS ONE policy (http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research) on papers that include identifying, or potentially identifying, information, the individual(s) or parent(s)/guardian(s) must be informed of the terms of the PLOS open-access (CC-BY) license and provide specific permission for publication of these details under the terms of this license. Please download the Consent Form for Publication in a PLOS Journal (http://journals.plos.org/plosone/s/file?id=8ce6/plos-consent-form-english.pdf). The signed consent form should not be submitted with the manuscript, but should be securely filed in the individual's case notes. Please amend the methods section and ethics statement of the manuscript to explicitly state that the patient/participant has provided consent for publication: “The individual in this manuscript has given written informed consent (as outlined in PLOS consent form) to publish these case details”.

If you are unable to obtain consent from the subject of the photograph, you will need to remove the figure and any other textual identifying information or case descriptions for this individual.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear author, I congratulate for your work.

I have no comment. Your paper is appropriate and I believe room there is minimum space for further improvement.

I could only suggest to provide a better image 3B that appear to be blurry (too much light?)

Reviewer #2: In this manuscript, the authors demonstrated a novel interface device that connects conventional needle-electrodes to BIS monitoring sensors, thereby enabling the indirect BIS monitoring without topographical problems. This, otherwise, would be impossible to achieve using any of existing BIS sensors whose validation is largely relies on the use of it on the forehead. This interface device showed a good agreement between direct and indirect BIS values (2582/2787; 92.64%) within a clinically acceptable 10-unit difference. The concept and the experimental demonstration are interesting which I believe this manuscript is acceptable for publication in this journal if the followings can be addressed.

1. In this study, the authors insist that they developed the novel interface device, which connects the BIS Vista system to conventional EEG needle-electrodes for indirect BIS monitoring. I wonder that this interface device is novel enough. This interface system is constructed by connecting two components that are commercially available (BIS sensor and needle electrodes). In addition, the studies are already reported showing the use of needle electrode for BIS monitoring (T. M. Hemmerling et al., Anesth Analg, 2002, 95:1675-7, S. A. Greene et al., Comp. Med. 2002, 52:424-8). Thus, it is recommended for the authors to provide the novelty of this study compared to the previously reported works.

2. In Figure 5D’ and Figure 6C, even though SQI value was not very closely matched between indirect and direct recordings, the authors claim that their effect on the BIS correlation was minimal. Why is there little correlation? Besides, SQI value not for direct recording but for indirect recording was only strongly affected by automatic impedance check (Figure 5D). Why is the indirect recording only vulnerable to automatic impedance check? Are those recording results reliable with low value of SQI?

3. By the way, there are typing errors:

- In page 21, line 393-394, EGM should be corrected to EMG.

- In Figure 7B, Y axis, “differece” should be corrected to “difference”.

Reviewer #3: The paper was well presented. The data supported the conclusions. A minor revision is needed. The authors did not make the data fully accessible. Only the results of statistical analyses are available in the manuscript.

Reviewer #4: The statistics are mainly regression with linear mixed models and the Bland Altman procedure for method comparison. These appear to be applied appropriately. However, there are major concerns.

1. The study lacks a reasonable statistical hypothesis for which the sample size of 18 to 21 should be justified in terms of the alpha level and anticipated power, even if the unit of analysis is otherwise. The entire design is not clear. Why so many points on Figure 7? This statistical justification should be provided.

2. The Bland Altman procedure (Figure 7) is suspect and poorly explained. There is a great bulk of points beyond what appears to be the lower (+10, -10) bias limit. This limit is not very meaningful as presented with so many points violating those limits especially on the low side. This is not convincing for agreement. Also, what exactly are the 95% limits and how do they actually affect the overall conclusion?

3. Figure 6, A prime does not support the conclusion of the paper. There does not appear to be an acceptable level of agreement of the indirect and direct BIS. What is the hypothesis test of the slope and intercept on this line, especially the test for intercept equal to 0 and the slope equal to one?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Alessandro De Cassai

Reviewer #2: Yes: Chi Hwan Lee

Reviewer #3: No

Reviewer #4: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Oct 21;16(10):e0258647. doi: 10.1371/journal.pone.0258647.r002

Author response to Decision Letter 0


1 Jun 2021

Dear Dr. Pasin,

Thank you very much for the review comments. We were very pleased to receive a chance to resubmit our manuscript and appreciate you and all reviewers for helping us to improve the manuscript. All comments were taken seriously, the manuscript was revised thoroughly, and we resubmit herewith our revised manuscript. Please find a separate letter, which include our point-by-point responses to the reviewers.

We would thank you very much for your consideration to publish our revised manuscript in PLOS ONE and hope the revised manuscript reached your criteria to accept it for publication.

Sincerely,

Miyuki Tauchi and Hideki Harada, on behalf of all coauthors

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Laura Pasin

21 Jul 2021

PONE-D-21-02149R1

Accuracy of BIS monitoring using a novel interface device connecting conventional needle-electrodes and BIS sensors during frontal neurosurgical procedures

PLOS ONE

Dear Dr. Harada,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we have decided that your manuscript does not meet our criteria for publication and must therefore be rejected.

I apologize for the long time you had to wait. Unfortunately it was very, very difficult to find reviewers.

My decision is based on the lack of formal testing on the estimates of intercept and slope, as pointed out by Reviewer #4. 

I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision.

Yours sincerely,

Laura Pasin

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #4: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #4: No

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #4: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #4: With respect to the BIS regressions, the reviewer asked:

What is the hypothesis test of the slope and intercept on this line, especially the test for intercept equal to 0 and the slope equal to one?

The authors responded:

No formal testing was performed on the estimates of intercept and slope. Of note, these data, although we believe the unstable BIS is an artefact because of neuromonitoring, are included in the formal testing described in the manuscript and plotted in Fig 7.

Such may be the case. However, an R-square less than 0.9 when considering agreement is not that convincing. At best, the agreement is weak, statistically.

In Figure 7A you want the intercept to be 0 and the slope to be one. A formal test not rejecting these null hypotheses that intercept=0 and slope=1 would convince one of agreement. That was the reason for requesting a formal test.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #4: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

- - - - -

For journal use only: PONEDEC3

PLoS One. 2021 Oct 21;16(10):e0258647. doi: 10.1371/journal.pone.0258647.r004

Author response to Decision Letter 1


19 Aug 2021

Dear Dr. Pasin,

Dear editors,

We are re-submitting our manuscript. We received a disappointing decision letter for our revised manuscript in July. We went through the review comments to understand the problem in the manuscript, but we could not convince ourselves from the review comments that our manuscript did not meet the quality required by PLOS ONE. We appreciate that you accepted our appeal and reconsider the manuscript after.

Herewith we submit our point-by-point response (as a separate file), and the manuscrips with and without tracking changes. We do not have any new changes in the manuscript since the last submission: the tracked changes are from the version after the first review.

Sincerely,

Hideki Harada

Miyuki Tauchi

Attachment

Submitted filename: point-by-point response.docx

Decision Letter 2

Laura Pasin

4 Oct 2021

Accuracy of BIS monitoring using a novel interface device connecting conventional needle-electrodes and BIS sensors during frontal neurosurgical procedures

PONE-D-21-02149R2

Dear Dr. Harada,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Laura Pasin

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for your email and additional response to reviewers. I acknowledge I did not fully understand the previous revision. I'm really sorry. Now everything is clear and I'm happy to accept your manuscript. 

Reviewers' comments:

Acceptance letter

Laura Pasin

11 Oct 2021

PONE-D-21-02149R2

Accuracy of BIS monitoring using a novel interface device connecting conventional needle-electrodes and BIS sensors during frontal neurosurgical procedures

Dear Dr. Harada:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Laura Pasin

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist

    (PDF)

    S2 Checklist

    (PDF)

    S1 Text. Statistical models.

    (DOCX)

    S1 File

    (PDF)

    S2 File

    (PDF)

    Attachment

    Submitted filename: Response to reviewers.docx

    Attachment

    Submitted filename: point-by-point response.docx

    Data Availability Statement

    All summarized data are presented in the manuscript. Other data are all kept as raw data with patients' information. Because the size of participants is small and the study site locates in a small city, there is a privacy concern. Requests can be addressed to the ethics committee, Clinical Research Center, Kurume University Hospital (i_rinri@kurume-u.ac.jp), or to the principal investigator (Hideki Harada).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES